Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Luger

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
The British Journal of Dermatology|January 30, 2004
Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programmeN Barbier, C Paul, T Luger, et al.
Journal of the American Academy of Dermatology|May 1, 1996
Expression of a glycoprotein of the carcinoembryonic antigen family in normal and neoplastic sebaceous glands. Limited role of carcinoembryonic antigen as a sweat gland markerD Metze, H P Soyer, B Zelger, et al.
European Journal of Immunology|August 1, 1994
Neuropeptides are potent modulators of human in vitro immunoglobulin E synthesisI Aebischer, M R Stämpfli, A Zürcher, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2020
Developments and challenges in dermatology: an update from the Interactive Derma Academy (IDeA) 2019T Luger, T Dirschka, K Eyerich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993
Human mast cells produce IL-8A Möller, U Lippert, D Lessmann, et al.
The British Journal of Dermatology|March 8, 2013
Skin metastases in metastatic uveal melanoma: GNAQ/GNA11 mutational analysis as a valuable toolA Tsianakas, M R R Böhm, V Getova, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 31, 2013
Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasisR Strohal, B Kirby, L Puig, et al.
Lupus|May 6, 2016
Fumaric acid ester treatment in cutaneous lupus erythematosus (CLE): a prospective, open-label, phase II pilot studyA Kuhn, A Landmann, N Patsinakidis, et al.
The British Journal of Dermatology|June 6, 2017
Secukinumab sustains good efficacy and favourable safety in moderate-to-severe psoriasis after up to 3 years of treatment: results from a double-blind extension studyR Bissonnette, T Luger, D Thaçi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 15, 2018
Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study)R Bissonnette, T Luger, D Thaçi, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
The British Journal of Dermatology|January 30, 2004
Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programmeN Barbier, C Paul, T Luger, et al.
Journal of the American Academy of Dermatology|May 1, 1996
Expression of a glycoprotein of the carcinoembryonic antigen family in normal and neoplastic sebaceous glands. Limited role of carcinoembryonic antigen as a sweat gland markerD Metze, H P Soyer, B Zelger, et al.
European Journal of Immunology|August 1, 1994
Neuropeptides are potent modulators of human in vitro immunoglobulin E synthesisI Aebischer, M R Stämpfli, A Zürcher, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2020
Developments and challenges in dermatology: an update from the Interactive Derma Academy (IDeA) 2019T Luger, T Dirschka, K Eyerich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1993
Human mast cells produce IL-8A Möller, U Lippert, D Lessmann, et al.
The British Journal of Dermatology|March 8, 2013
Skin metastases in metastatic uveal melanoma: GNAQ/GNA11 mutational analysis as a valuable toolA Tsianakas, M R R Böhm, V Getova, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 31, 2013
Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasisR Strohal, B Kirby, L Puig, et al.
Lupus|May 6, 2016
Fumaric acid ester treatment in cutaneous lupus erythematosus (CLE): a prospective, open-label, phase II pilot studyA Kuhn, A Landmann, N Patsinakidis, et al.
The British Journal of Dermatology|June 6, 2017
Secukinumab sustains good efficacy and favourable safety in moderate-to-severe psoriasis after up to 3 years of treatment: results from a double-blind extension studyR Bissonnette, T Luger, D Thaçi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 15, 2018
Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study)R Bissonnette, T Luger, D Thaçi, et al.
Pageof 11